Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS approval · 2012-12-13Clinical Trial Update: Expanded Access Program for Aztreonam Lysine for Inhalation in Canadian Patients With Cystic Fibrosis
Expanded access program update for aztreonam lysine inhalation (Cayston) in Canadian cystic fibrosis patients, noting marketing approval sta…
-
CLINICAL_TRIALS withdrawal · 2012-12-11Clinical Trial Update: Sildenafil Trial in Children and Young Adults With CF [Phase 1, Phase 2]
Phase 1/2 trial of sildenafil in children and young adults with cystic fibrosis and mild-to-moderate lung disease was withdrawn. The study s…
-
FDA approval · 2012-12-07FDA Approved: PANCREAZE — Supplemental Application (VIVUS LLC)
The FDA granted a supplemental approval for PANCREAZE (pancrelipase) to VIVUS LLC.
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: Effect of Lactobacillus Reuteri in Cystic Fibrosis [Phase 4]
A Phase 4 clinical trial evaluating the effects of Lactobacillus reuteri in cystic fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: Time to Perform Lung Function Test in Cystic Fibrosis [NA]
A completed clinical trial from Karolinska University Hospital examined the time required to perform a lung function test in cystic fibrosis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-11-20FDA Approved: CREON — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for CREON (pancrelipase) submitted by AbbVie Inc. The action involves modifications to the produ…
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: Osteopathic Treatment in Adult Patients With Cystic Fibrosis [Phase 3]
A Phase 3 trial evaluating osteopathic treatment in adult patients with cystic fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders [NA]
The clinical trial examining hyperpolarized noble gas MRI for pulmonary disorders, including COPD and cystic fibrosis, was terminated with r…
-
CLINICAL_TRIALS trial_result · 2012-10-15Clinical Trial Update: Safety and Efficacy of an Antioxidant-rich Multivitamin Supplement in Cystic Fibrosis [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating the safety and potential efficacy of an antioxidant-rich multivitamin supplement in cystic fibrosis ha…
-
CLINICAL_TRIALS research · 2012-10-15Clinical Trial Update: Combined Inspiratory Muscle and 'Whole Muscle' Training in Children With Cystic Fibrosis [NA]
Clinical trial evaluating combined inspiratory muscle and whole-body muscle training in children with cystic fibrosis has completed.
-
FDA approval · 2012-10-12FDA Approved: TOBRAMYCIN INHALATION — Original Application (Prasco, LLC)
The FDA approved an Original Application for Tobramycin Inhalation by Prasco, LLC, for the treatment of chronic Pseudomonas aeruginosa infec…
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: Safety Study of Ivacaftor in Subjects With Cystic Fibrosis [Phase 2]
Phase 2 safety study of Ivacaftor in subjects with cystic fibrosis completed. Results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-03Clinical Trial Update: A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo [Phase 3]
This Phase 3 trial compared Tobramycin Inhalation Powder from a modified manufacturing process with placebo in cystic fibrosis, with results…
-
CLINICAL_TRIALS research · 2012-10-02Clinical Trial Update: Airway Secretion Clearance in Cystic Fibrosis [NA]
The clinical trial evaluating airway secretion clearance in cystic fibrosis sponsored by the University of Colorado, Denver has been termina…
-
FDA approval · 2012-09-24FDA Approved: CAYSTON — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Cayston (aztreonam) submitted by Gilead Sciences. This action updates the product’s labeling…
-
FDA approval · 2012-08-28FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
FDA approved a supplemental application for KALYDECO (ivacaftor) by Vertex Pharmaceuticals Incorporated, resulting in an updated regulatory …
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation [Phase 3]
Phase 3 trial results for ivacaftor in children aged 6 to 11 with the G551D CF mutation; results were posted after completion.
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation [Phase 3]
A Phase 3 study of ivacaftor in cystic fibrosis patients aged 12 and older with the G551D CFTR mutation completed, and results were posted i…
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis [Phase 1]
Phase 1 clinical trial update examines how durable the benefits of inhaled hypertonic saline are for improving mucociliary clearance in cyst…
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Homozygous for the F508del-CFTR Mutation [Phase 2]
Phase 2 study of ivacaftor in cystic fibrosis patients aged 12 and older homozygous for the F508del-CFTR mutation was terminated; results we…
-
CLINICAL_TRIALS research · 2012-08-17Clinical Trial Update: Clinical Evaluation of NeoPlex4 Assay and NeoPlex System
This update notes the completed clinical evaluation of Luminex's NeoPlex4 Assay and NeoPlex System, assessing tests for congenital adrenal h…
-
CLINICAL_TRIALS trial_result · 2012-08-10Clinical Trial Update: Comparison of the Tolerability of Two Formulations of Hypertonic Saline in Cystic Fibrosis Patients [NA]
This clinical trial update reports a tolerability comparison between two hypertonic saline formulations in patients with cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2012-07-25Clinical Trial Update: A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic Fibrosis [Phase 2]
Phase II, placebo-controlled trial evaluating 28-day oral AZD9668 in patients with cystic fibrosis; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-07-24Clinical Trial Update: Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis [Phase 3]
Phase 3 trial comparing the safety of Tobramycin Inhalation Powder (TIP) to Tobramycin Inhalation Solution in cystic fibrosis patients; resu…
-
CLINICAL_TRIALS trial_result · 2012-07-24Clinical Trial Update: Tobramycin 300 mg Once-a-day (o.d.) Aerosol in Adults With Cystic Fibrosis [Phase 4]
This is a Phase 4 clinical trial update for once-daily inhaled tobramycin (300 mg) in adults with cystic fibrosis. The trial status is compl…